Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
European Journal of Cancer & Clinical Oncology|January 1, 1989
Treatment of human clonogenic tumor cells and bone marrow progenitor cells with bleomycin and peplomycin under 40.5 degrees C hyperthermia in vitroH A Neumann, D B Herrmann, H H Fiebig, et al.Lipids|November 1, 1987
Synthesis of thioether phosphocholine analoguesE Bosies, D B Herrmann, U Bicker, et al.Lipids|November 1, 1987
Pharmacokinetics of the thioether phospholipid analogue BM 41.440 in ratsD B Herrmann, E Besenfelder, U Bicker, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|March 1, 1993
Antileishmanial activity of the ether phospholipid ilmofosineS L Croft, R A Neal, E A Thornton, et al.Lipids|April 1, 1989
Synergistic enhancement of the antiproliferative activity of cis-diamminedichloroplatinum(II) by the ether lipid analogue BM41440, an inhibitor of protein kinase CJ Hofmann, F Ueberall, L Posch, et al.Electrophoresis|September 1, 1992
Preparative continuous separation of biological particles by means of free-flow magnetophoresis in a free-flow electrophoresis chamberR Hartig, M Hausmann, J Schmitt, et al.Lipids|November 1, 1987
Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patientsD B Herrmann, H A Neumann, W E Berdel, et al.British Journal of Cancer|January 1, 1997
Resistance to the new anti-cancer phospholipid ilmofosine (BM 41 440)J Hofmann, I Utz, M Spitaler, et al.Antiviral Chemistry & Chemotherapy|January 6, 1999
In vitro evaluation and characterization of newly designed alkylamidophospholipid analogues as anti-human immunodeficiency virus type 1 agentsL S Kucera, N Iyer, S L Morris-Natschke, et al.Antiviral Therapy|May 1, 2001
Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trialJ R Bogner, M Roecken, D B Herrmann, et al.Pageof 3